Tricuspid Valve Replacement Is a Game Changer
Presenter
Firas E. Zahr, MD, FSCAI, OHSU Knight Cardiovascular Institute, Portland, OR
Firas E. Zahr, MD, FSCAI, OHSU Knight Cardiovascular Institute, Portland, OR
Learning Objectives:
- Give an example of a case of Evoque TTVR (fluoro, echo)
- Discuss ongoing trials, share outcomes of TRISCEND I
- Identify who is a candidate (CT and clinical factors)
Keywords: Structural Heart Disease (SHD) and TTVR/Tricuspid Valve